Felicia Osadi

About Felicia Osadi

I am a Global Product Manager with a strong scientific foundation in molecular diagnostics and immunology, specializing in launching and managing complex diagnostic portfolios across global markets. At Bio-Rad, I lead end-to-end lifecycle management for multimillion-dollar QC and EQA product lines, driving portfolio growth, streamlining product offerings, and executing global go-to-market strategies that enable commercial success. Previously at Thermo Fisher Scientific, I supported the development of molecular diagnostic kits for post-transplant testing (HLA, HPA, KIR), collaborating with cross-functional teams to improve workflows, ensure quality, and accelerate time to market. I bring expertise in market development, Voice of Customer collection, forecasting, and competitive intelligence, combined with the business acumen to translate technical benefits into clear clinical and commercial value. Passionate about bridging science and strategy, I thrive in cross-functional environments that drive innovation and deliver meaningful impact for customers and patients worldwide.

Experience

1. Global Product Manager

   Bio-Rad Laboratories

   Jul 2023 — Present · Irvine, CA, US

   Led the global launch and go-to-market strategy for the EQAS Specialty Immunoassay portfolio, partnering with R&D, Regulatory, Ops, Manufacturing, and Sales to define value proposition.• Developed go-to-market package (sales training, launch playbook, customer-facing collateral) and train 80+ commercial team members, ensuring consistent global messaging.• Coordinated labeling, logistics, and supply chain for seamless global rollout.• Manage end-to-end lifecycle for Urinalysis QC ($16M), Tumor Marker QC ($45M), and EQA ($10M), aligning positioning to market needs and supporting commercial inquiries.• Streamlined the Urinalysis QC portfolio, optimizing product offerings to improve gross margin and eliminate $1.3M in backorders to restore supply reliability.• Drove Tumor Marker QC growth, achieving 13.4% CAGR (20••••24) through targeted lifecycle and market strategies.• Increase EQA participation by 3%(20••••24) via customer insights and market-driven initiatives.• Leveraged market research, forecasting, and competitive analysis to inform portfolio decisions and identify growth opportunities, including adjacent markets.• Collected and analyzed VoC feedback through field visits, sales input, and 8-minute gemba sessions to shape upstream (R&D/product planning) and downstream (marketing/sales) strategies.• Identified process gaps in the customer notification process, leading CDG level initiatives that reduce notification volume and streamline approval timelines.• Collaborated cross-functionally to resolve quality issues promptly, minimizing customer impact and maintaining product integrity.

Education

• Santa Monica College

  Associate of Arts - AA

  2016 — 2017

• Santa Monica College

  Biology/Biological Sciences

  2009 — 2012

• UCLA

  Bachelor of Science (BS)

  2012 — 2014

• UCLA

  Master's degree

  2017 — 2019